Non-cirrhotic portal hypertension in the HIV-infected individual.
作者信息
Fernando K A, Bhaduri S, Hubscher S, Radcliffe K W
机构信息
Department of Sexual Health & HIV Medicine, Southend University Hospital NHS Foundation Trust, Prittlewell Chase, Essex SS0 0RY, UK.
出版信息
J R Soc Med. 2013 Mar;106(3):105-7. doi: 10.1177/0141076813479194.
Abstract
摘要
相似文献
1
Non-cirrhotic portal hypertension in the HIV-infected individual.
J R Soc Med. 2013 Mar;106(3):105-7. doi: 10.1177/0141076813479194.
2
Non-cirrhotic portal hypertension in HIV mono-infected patients.
J Gastroenterol Hepatol. 2012 Sep;27(9):1512-9. doi: 10.1111/j.1440-1746.2012.07148.x.
3
A case of non-cirrhotic portal hypertension associated with anti-retroviral therapy in a Japanese patient with human immunodeficiency virus infection.
J Infect Chemother. 2014 Sep;20(9):582-5. doi: 10.1016/j.jiac.2014.06.005. Epub 2014 Jul 15.
4
Noncirrhotic portal hypertension: another cause of liver disease in HIV patients.
Ann Hepatol. 2009 Oct-Dec;8(4):390-5.
5
Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings.
AIDS. 2010 May 15;24(8):1171-6. doi: 10.1097/QAD.0b013e3283389e26.
6
[Non-cirrhotic portal hypertension due to didanosina. A rare case].
Rev Gastroenterol Peru. 2017 Jan-Mar;37(1):87-90.
7
Noncirrhotic Portal Hypertension in Perinatally HIV-infected Adolescents Treated With Didanosine-containing Antiretroviral Regimens in Childhood.
Pediatr Infect Dis J. 2016 Aug;35(8):e248-52. doi: 10.1097/INF.0000000000001202.
8
Liver Disease in Human Immunodeficiency Virus Infection.
Clin Liver Dis. 2019 May;23(2):309-329. doi: 10.1016/j.cld.2018.12.011. Epub 2019 Mar 5.
9
[A puzzling case of portal hypertension in a patient with human immunodeficiency and hepatitis C virus co-infection].
Gastroenterol Clin Biol. 2007 Oct;31(10):878-80. doi: 10.1016/s0399-8320(07)73984-2.
10
Idiopathic non-cirrhotic portal hypertension and portal vein thrombosis in a patient with HIV infection.
Gastroenterol Hepatol. 2017 May;40(5):353-354. doi: 10.1016/j.gastrohep.2016.03.005. Epub 2016 Apr 12.
本文引用的文献
1
Non-cirrhotic portal hypertension in HIV-infected individuals.
Int J STD AIDS. 2011 Jun;22(6):324-8. doi: 10.1258/ijsa.2010.010396.
2
Anticoagulant therapy for nodular regenerative hyperplasia in a HIV-infected patient.
BMC Gastroenterol. 2010 Jan 18;10:6. doi: 10.1186/1471-230X-10-6.
3
Noncirrhotic portal hypertension: another cause of liver disease in HIV patients.
Ann Hepatol. 2009 Oct-Dec;8(4):390-5.
4
Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment.
Hepatol Int. 2007 Sep;1(3):398-413. doi: 10.1007/s12072-007-9010-9. Epub 2007 Sep 11.
5
Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study.
Clin Infect Dis. 2009 Aug 15;49(4):626-35. doi: 10.1086/603559.
6
Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients.
AIDS. 2009 Jul 31;23(12):1511-8. doi: 10.1097/QAD.0b013e32832bfa51.
7
Nodular regenerative hyperplasia of the liver: an under-recognized cause of portal hypertension in hematological disorders.
Am J Hematol. 2004 Apr;75(4):225-30. doi: 10.1002/ajh.20024.
Zotero 插件